transcripts

Transcript, Meeting 12 Session 5

DR. GUTMANN:  Good morning, everybody, I'm Amy Gutmann. I’m President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues, and I welcome you all here to day two of our 12th meeting of this Commission and happy to do so on behalf of myself and Vice Chair of the Commission and President of Emory University, President Jim Wagner.

Date

Tue, 01/15/2013

Transcript, Meeting 12 Session 3

DR. GUTMANN:  I’m going to ask our commission members to assemble so we can get started, and welcome everybody back from lunch. 

           We’re going to turn to the ethical considerations associated with pre-event medical countermeasure (MCM) research and such studies -- just to frame -- present no prospect of direct benefit to participants because prior to an event or an imminent event, no children will be affected by the condition that the countermeasure is designed to treat.  And generally, research with children must pose no greater than minimal risk to participants. 

Date

Mon, 01/14/2013

Transcript, Meeting 12 Session 4

DR. WAGNER: Let's all gather.

           Okay, I believe all who are available here are assembled, and Dr. Beauchamp will join us by video conference.  Tom, can you see and hear us?

           DR. BEAUCHAMP:  Yes, I can see and hear you.

Date

Mon, 01/14/2013

Transcript, Meeting 12 Session 6

 

DR. WAGNER:  Welcome back, Commissioners. We're about to commence on our final session and what we want to do is talk about a specific future topic, obviously there are many we could pursue, but as you will see, I think we have a special interest, if not obligation to be looking at a future topic on Incidental Findings.

Date

Tue, 01/15/2013

Transcript, Meeting 12 Session 1

DR. GUTMANN:  Welcome, everybody. I'm Amy Gutmann.  I'm President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues. On behalf of myself and our Vice Chair, James Wagner, the President of Emory University, I'd like to welcome you to our 12th meeting.

Date

Mon, 01/14/2013

Transcript, Meeting 11, Session 3

DR. WAGNER:  So, let’s get started. 

                       

                        We are shifting now from, um, uh, pre-event discussions to post event.  MCM use, medical countermeasures use and research and post-event scenarios, and we will again, the format, we’ll ask each of you to make your presentations, and then open it for questions.

                       

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 7

DR. GUTMANN:  Welcome back everybody.  We have until 11:45, right?  Great.  So, we'll take an hour and then wrap up. 

Date

Tue, 11/06/2012

Pages

Subscribe to RSS - transcripts